Darwin Global Management, Ltd. Portfolio Holdings
Darwin Global Management, Ltd.
- $586 Million
- Q1 2024
Darwin Global Management, Ltd. has filed its 13F form on May 15, 2024 for Q1 2024 where it was disclosed a total value porftolio of $586 Million distributed in 12 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Vaxcyte, Inc. with a value of $188M, Nuvalent, Inc. with a value of $108M, Keros Therapeutics, Inc. with a value of $95.1M, Alpine Immune Sciences, Inc. with a value of $78.6M, and Beam Therapeutics Inc. with a value of $70M.
Examining the 13F form we can see an increase of $315M in the current position value, from $272M to 586M.
Darwin Global Management, Ltd. is based out at St. Helier, Y9
Below you can find more details about Darwin Global Management, Ltd. portfolio as well as his latest detailed transactions.